Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer

Anti-PD-1 therapy has shown promising outcomes in the treatment of different types of cancer. It is of fundamental interest to analyze the efficacy of anti-PD-1 therapy in cancer patients infected with hepatitis B virus (HBV) since the comorbidity of HBV and cancer is widely documented. We designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jie, Chen, Guanming, Wang, Jiuling, Zhou, Bo, Sun, Xuemin, Wang, Jinsong, Tang, Shu, Xing, Xiangju, Hu, Xiaofei, Zhao, Yang, Peng, Yu, Shi, Wenjiong, Zhao, Tingting, Wu, Yuzhang, Zhong, Hanbing, Hong, Ni, Ruan, Zhihua, Zhang, Yi, Jin, Wenfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119302/
https://www.ncbi.nlm.nih.gov/pubmed/37080999
http://dx.doi.org/10.1038/s41389-023-00468-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119302/
https://www.ncbi.nlm.nih.gov/pubmed/37080999
http://dx.doi.org/10.1038/s41389-023-00468-0

Ejemplares similares